Brief: Noxopharm Ltd Seeks Trading Halt
19/08/2021 24:56
Aug 19 (Reuters) - Noxopharm Ltd NOX.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT RELATING TO UPDATE
ON
CO'S NOXCOVID CLINICAL PROGRAM AND VEYONDA® DRUG CANDIDATE
Source text for Eikon: ID:nASX9xZlmw
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer